Clinical Trial Update: Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating conversion from epoetin alfa to monthly peginesatide injections in chronic kidney disease patients on dialysis; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• Peginesatide (peginesatide)

Snippet

Sponsor: Takeda | Conditions: Chronic Kidney Disease, Anemia | Phase 3 | Status: COMPLETED | Results posted: 2014-05-26